Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia
ConditionInsomnia, Primary
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCapital Medical University
About this trial
The purpose of this study was to understand the effectiveness of intermittent hypoxia in the treatment of primary insomnia.
Eligibility criteria
Qualifiers
Subjects are diagnosed with primary insomnia between 18 and 60 years old，gender is not limited.
Patients who are not taking sedative-hypnotic drugs or have stopped taking drugs for more than 2 weeks.
Residing in the plains all year round and not having been above 1500 meters above sea level in the past 30 days.
Quiet state SaO2 ≥ 90%, cerebral oxygen saturation 58-82%, heart rate 60-100 beats/min, blood pressure 90-140/60-90 mmHg, respiratory rate 16-20 times/min.
Disqualifiers
Stroke onset in the past 3 months, other severe neurological diseases, such as epilepsy, intracranial infectious diseases or demyelination.
Uncontrolled hypertension (systolic blood pressure ≥200mmHg) with antihypertensive drugs before enrollment, other cardiovascular diseases.
History of pulmonary, hepatic, dermatologic, or hematologic diseases.
History of substance abuse.
Trial design
Treatments tested in this trial
- Intermittent Hypoxia
- Sham Intermittent Hypoxia
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov